MiR12875p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3kinase CB thereby sensitizing cells for PI3Kinase inhibitors
Bioportfolio,
Non-coding RNAs and especially microRNAs have been discovered to act as master regulators of cancer initiation and progression.